MYGN Competitors & Alternatives
Compare Myriad Genetics Inc with similar stocks in the same industry
Diagnostics & Research
MYGN
Main Stock$3.06
Tradestie Score
65
Market Cap
$719.23M
Revenue Growth
-0.2%
Analyst Upside
+29.5%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$76.81
|
$2.24B | - | 40 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.72
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$138.52
|
$1.77B | - | 42 | Compare |
|
NEOG
Neogen Corp
|
$11.67
|
$1.26B | - | 42 | Compare |
|
OPK
Opko Health Inc.
|
$1.49
|
$1.23B | - | 39 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.47
|
$1.13B | - | 40 | Compare |
|
CDNA
CareDx, Inc.
|
$47.67
|
$798.40M | 22.4 | 35 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$19.38
|
$719.31M | - | 53 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$33.84
|
$667.77M | - | 33 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$17.13
|
$612.76M | - | 44 | Compare |
More MYGN Analysis
Data updated: Aug 24, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry